Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa A Frick

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Clinical Lung Cancer|November 15, 2025
Association Between Inter-Fraction Volume Changes and Patient Outcomes from Stereotactic Ablative Radiotherapy for Early-Stage Lung CancerWilson X Mai, Melissa A Frick, Scott Jackson, et al.
International Journal of Radiation Oncology, Biology, Physics|September 25, 2018
Circulating Tumor Cell Assessment in Presumed Early Stage Non-Small Cell Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy: A Prospective Pilot StudyMelissa A Frick, Gary D Kao, Louise Aguarin, et al.
International Journal of Radiation Oncology, Biology, Physics|March 4, 2021
Multiblock Discriminant Analysis of Integrative <sup>18</sup>F-FDG-PET/CT Radiomics for Predicting Circulating Tumor Cells in Early-Stage Non-small Cell Lung Cancer Treated With Stereotactic Body Radiation TherapySang Ho Lee, Gary D Kao, Steven J Feigenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2020
Circulating Tumor Cells Are Associated with Recurrent Disease in Patients with Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body RadiotherapyMelissa A Frick, Steven J Feigenberg, Samuel R Jean-Baptiste, et al.
Brachytherapy|March 2, 2025
The NorCal brachytherapy waste audit: A simple, validated, toolkit for clinician led waste reductionClaire C Baniel, Katie E Lichter, Melissa A Frick, et al.
Plos One|July 11, 2013
The Embryonic Transcriptome of the Red-Eared Slider Turtle (Trachemys scripta)Nicholas J Kaplinsky, Scott F Gilbert, Judith Cebra-Thomas, et al.
Practical Radiation Oncology|October 24, 2022
Radiation Therapy for Endometrial Cancer: An American Society for Radiation Oncology Clinical Practice GuidelineMatthew M Harkenrider, Nadeem Abu-Rustum, Kevin Albuquerque, et al.
Clinical Lung Cancer|October 20, 2018
Five-year Long-term Outcomes of Stereotactic Body Radiation Therapy for Operable Versus Medically Inoperable Stage I Non-small-cell Lung Cancer: Analysis by Operability, Fractionation Regimen, Tumor Size, and Tumor LocationCaitlin A Schonewolf, Marina Heskel, Abigail Doucette, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Clinical Lung Cancer|November 15, 2025
Association Between Inter-Fraction Volume Changes and Patient Outcomes from Stereotactic Ablative Radiotherapy for Early-Stage Lung CancerWilson X Mai, Melissa A Frick, Scott Jackson, et al.
International Journal of Radiation Oncology, Biology, Physics|September 25, 2018
Circulating Tumor Cell Assessment in Presumed Early Stage Non-Small Cell Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy: A Prospective Pilot StudyMelissa A Frick, Gary D Kao, Louise Aguarin, et al.
International Journal of Radiation Oncology, Biology, Physics|March 4, 2021
Multiblock Discriminant Analysis of Integrative <sup>18</sup>F-FDG-PET/CT Radiomics for Predicting Circulating Tumor Cells in Early-Stage Non-small Cell Lung Cancer Treated With Stereotactic Body Radiation TherapySang Ho Lee, Gary D Kao, Steven J Feigenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2020
Circulating Tumor Cells Are Associated with Recurrent Disease in Patients with Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body RadiotherapyMelissa A Frick, Steven J Feigenberg, Samuel R Jean-Baptiste, et al.
Brachytherapy|March 2, 2025
The NorCal brachytherapy waste audit: A simple, validated, toolkit for clinician led waste reductionClaire C Baniel, Katie E Lichter, Melissa A Frick, et al.
Plos One|July 11, 2013
The Embryonic Transcriptome of the Red-Eared Slider Turtle (Trachemys scripta)Nicholas J Kaplinsky, Scott F Gilbert, Judith Cebra-Thomas, et al.
Practical Radiation Oncology|October 24, 2022
Radiation Therapy for Endometrial Cancer: An American Society for Radiation Oncology Clinical Practice GuidelineMatthew M Harkenrider, Nadeem Abu-Rustum, Kevin Albuquerque, et al.
Clinical Lung Cancer|October 20, 2018
Five-year Long-term Outcomes of Stereotactic Body Radiation Therapy for Operable Versus Medically Inoperable Stage I Non-small-cell Lung Cancer: Analysis by Operability, Fractionation Regimen, Tumor Size, and Tumor LocationCaitlin A Schonewolf, Marina Heskel, Abigail Doucette, et al.
Pageof 2